Zhang Shi-Lei, Liu Jia-Li, Gong Fu-Kai, Yang Jian-Hua, Hu Jun-Ping
School of Pharmacy, Xinjiang Medical University Urumqi 830011, China School of Public Health, Xinjiang Medical University Urumqi 830011, China.
School of Pharmacy, Xinjiang Medical University Urumqi 830011, China.
Zhongguo Zhong Yao Za Zhi. 2023 Mar;48(5):1330-1342. doi: 10.19540/j.cnki.cjcmm.20221201.701.
This study aimed to explore the mechanism of Cistanches Herba in the treatment of cancer-induced fatigue(CRF) by network pharmacology combined with in vivo and in vitro experiments to provide a theoretical basis for the clinical medication. The chemical constituents and targets of Cistanches Herba were searched from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP). The targets of CRF were screened out by GeneCards and NCBI. The common targets of traditional Chinese medicine and disease were selected to construct a protein-protein interaction(PPI) network, followed by Gene Ontology(GO) functional and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analyses. A visual signal pathway rela-ted to Chinese medicine and disease targets was constructed. The CRF model was induced by paclitaxel(PTX) in mice. Mice were divided into a control group, a PTX model group, and low-and high-dose Cistanches Herba extract groups(250 and 500 mg·kg(-1)). The anti-CRF effect in mice was evaluated by open field test, tail suspension test, and exhaustive swimming time, and the pathological morphology of skeletal muscle was evaluated by hematoxylin-eosin(HE) staining. The cancer cachexia model in C2C12 muscle cells was induced by C26 co-culture, and the cells were divided into a control group, a conditioned medium model group, and low-, medium-, and high-dose Cistanches Herba extract groups(62.5, 125, and 250 μg·mL(-1)). The reactive oxygen species(ROS) content in each group was detected by flow cytometry, and the intracellular mitochondrial status was evaluated by transmission electron microscopy. The protein expression levels of hypoxia-inducible factor-1α(HIF-1α), BNIP3L, and Beclin-1 were detected by Western blot. Six effective constituents were screened out from Cistanches Herba. The core genes of Cistanches Herba in treating CRF were AKT1, IL-6, VEGFA, CASP3, JUN, EGFR, MYC, EGF, MAPK1, PTGS2, MMP9, IL-1B, FOS, and IL10, and the pathways related to CRF were AGE-RAGE and HIF-1α. Through GO enrichment analysis, it was found that the main biological functions involved were lipid peroxidation, nutrient deficiency, chemical stress, oxidative stress, oxygen content, and other biological processes. The results of the in vivo experiment showed that Cistanches Herba extract could significantly improve skeletal muscle atrophy in mice to relieve CRF. The in vitro experiment showed that Cistanches Herba extract could significantly reduce the content of intracellular ROS, the percentage of mitochondrial fragmentation, and the protein expression of Beclin-1 and increase the number of autophagosomes and the protein expression of HIF-1α and BNIP3L. Cistanches Herba showed a good anti-CRF effect, and its mechanism may be related to the key target proteins in the HIF-1α signaling pathway.
本研究旨在通过网络药理学结合体内外实验,探索肉苁蓉治疗癌症相关性疲劳(CRF)的机制,为临床用药提供理论依据。从中药系统药理学数据库与分析平台(TCMSP)检索肉苁蓉的化学成分和靶点。通过GeneCards和NCBI筛选CRF的靶点。选取中药与疾病的共同靶点构建蛋白质-蛋白质相互作用(PPI)网络,随后进行基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路富集分析。构建与中药和疾病靶点相关的可视化信号通路。用紫杉醇(PTX)诱导小鼠建立CRF模型。将小鼠分为对照组、PTX模型组以及低、高剂量肉苁蓉提取物组(250和500 mg·kg⁻¹)。通过旷场试验、悬尾试验和力竭游泳时间评估小鼠抗CRF效果,并用苏木精-伊红(HE)染色评估骨骼肌病理形态。通过C26共培养诱导C2C12肌肉细胞建立癌症恶病质模型,将细胞分为对照组、条件培养基模型组以及低、中、高剂量肉苁蓉提取物组(62.5、125和250 μg·mL⁻¹)。采用流式细胞术检测各组活性氧(ROS)含量,用透射电子显微镜评估细胞内线粒体状态。通过蛋白质免疫印迹法检测缺氧诱导因子-1α(HIF-1α)、BNIP3L和Beclin-1的蛋白表达水平。从肉苁蓉中筛选出6种有效成分。肉苁蓉治疗CRF的核心基因有AKT1、IL-6、VEGFA、CASP3、JUN、EGFR、MYC、EGF、MAPK1、PTGS2、MMP9、IL-1B、FOS和IL10,与CRF相关的通路有晚期糖基化终末产物受体(AGE-RAGE)和HIF-1α。通过GO富集分析发现,主要涉及的生物学功能有脂质过氧化、营养缺乏、化学应激、氧化应激、氧含量等生物学过程。体内实验结果表明,肉苁蓉提取物可显著改善小鼠骨骼肌萎缩以缓解CRF。体外实验表明,肉苁蓉提取物可显著降低细胞内ROS含量、线粒体碎片化百分比以及Beclin-1蛋白表达,增加自噬体数量以及HIF-1α和BNIP3L蛋白表达。肉苁蓉显示出良好的抗CRF效果,其机制可能与HIF-1α信号通路中的关键靶蛋白有关。